Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response.
Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes.
Organic compounds that contain two nitro groups attached to a phenol.
Immunologic adjuvant and sensitizing agent.
Irritants and reagents for labeling terminal amino acid groups.
'Nitrobenzenes' are organic compounds characterized by the presence of a nitro group (-NO2) attached to a benzene ring, with the molecular formula C6H5NO2, which can be hazardous and toxic, and have various applications in industry, such as solvents, dyes, and explosives.
Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS.
Benzene derivatives which are substituted with three nitro groups in any position.
Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies.
Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.
The processes triggered by interactions of ANTIBODIES with their ANTIGENS.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool.
Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.
Nitrophenols are organic compounds characterized by the presence of a nitro group (-NO2) attached to a phenol molecule, known for their potential use in chemical and pharmaceutical industries, but also recognized as environmental pollutants due to their toxicity and potential carcinogenicity.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
Hemocyanin is a copper-containing, oxygen-carrying protein found primarily in the blood of mollusks and arthropods, functioning to reversibly bind and transport oxygen in a manner analogous to hemoglobin in vertebrates.
Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID.
Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.
A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed)
Serum albumin from cows, commonly used in in vitro biological studies. (From Stedman, 25th ed)
Sites on an antigen that interact with specific antibodies.
Substances that are recognized by the immune system and induce an immune reaction.
Azo compounds are organic compounds characterized by the presence of one or more azo groups, -N=N-, linking two aromatic rings, which can impart various colors and are used in dyes, pharmaceuticals, and chemical research.
Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS.
Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.

Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. (1/1320)

Contact hypersensitivity (CHS) is a T cell-mediated skin inflammation induced by epicutaneous exposure to haptens in sensitized individuals. We have previously reported that CHS to dinitrofluorobenzene in mice is mediated by major histocompatibility complex (MHC) class I-restricted CD8(+) T cells. In this study, we show that CD8(+) T cells mediate the skin inflammation through their cytotoxic activity. The contribution of specific cytotoxic T lymphocytes (CTLs) to the CHS reaction was examined both in vivo and in vitro, using mice deficient in perforin and/or Fas/Fas ligand (FasL) pathways involved in cytotoxicity. Mice double deficient in perforin and FasL were able to develop hapten-specific CD8(+) T cells in the lymphoid organs but did not show CHS reaction. However, they did not generate hapten-specific CTLs, demonstrating that the CHS reaction is dependent on cytotoxic activity. In contrast, Fas-deficient lpr mice, FasL-deficient gld mice, and perforin-deficient mice developed a normal CHS reaction and were able to generate hapten-specific CTLs, suggesting that CHS requires either the Fas/FasL or the perforin pathway. This was confirmed by in vitro studies showing that the hapten-specific CTL activity was exclusively mediated by MHC class I-restricted CD8(+) T cells which could use either the perforin or the Fas/FasL pathway for their lytic activity. Thus, cytotoxic CD8(+) T cells, commonly implicated in the host defence against tumors and viral infections, could also mediate harmful delayed-type hypersensitivity reactions.  (+info)

Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis. (2/1320)

Competitive and standard enzyme-linked immunosorbent assays (ELISAs), rose bengal (RB), complement fixation, and agar gel immunoprecipitation with native hapten (AGID-NH) were compared by using sera from Brucella-free, Brucella melitensis-infected, and B. melitensis Rev1-vaccinated sheep. The most sensitive tests were indirect ELISA and RB, and the most specific tests were AGID-NH and competitive ELISA. We show that RB followed by AGID-NH is a simple and effective system for diagnosing sheep brucellosis.  (+info)

Receptor-mediated targeting of fluorescent probes in living cells. (3/1320)

A strategy was developed to label specified sites in living cells with a wide selection of fluorescent or other probes and applied to study pH regulation in Golgi. cDNA transfection was used to target a single-chain antibody to a specified site such as an organelle lumen. The targeted antibody functioned as a high affinity receptor to trap cell-permeable hapten-fluorophore conjugates. Synthesized conjugates of a hapten (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one, phOx) and fluorescent probes (Bodipy Fl, tetramethylrhodamine, fluorescein) were bound with high affinity (approximately 5 nM) and specific localization to the single-chain antibody expressed in the endoplasmic reticulum, Golgi, and plasma membrane of living Chinese hamster ovary cells. Using the pH-sensitive phOx-fluorescein conjugate and ratio imaging microscopy, pH was measured in the lumen of Golgi (pH 6.25 +/- 0.06). Measurements of pH-dependent vacuolar H+/ATPase pump activity and H+ leak in Golgi provided direct evidence that resting Golgi pH is determined by balanced leak-pump kinetics rather than the inability of the H+/ATPase to pump against an electrochemical gradient. Like expression of the green fluorescent protein, the receptor-mediated fluorophore targeting approach permits specific intracellular fluorescence labeling. A significant advantage of the new approach is the ability to target chemical probes with custom-designed spectral and indicator properties.  (+info)

Fine specificity and MHC restriction of trinitrophenyl-specific CTL. (4/1320)

In this study, the fine specificity and MHC restriction of a CTL response specific to the trinitrophenyl (TNP) hapten was analyzed. Based on the structure of peptide/Kb complexes and ternary TCR/Ag/MHC complexes, four TNP peptides, two octamers, and two nonamers were chosen for eliciting anti-TNP CTL responses. Hapten was conjugated at position 4 in the octamers and at position 5 in the nonamers, positions which should allow engagement of the hapten by TCRs. Potent CTL activity for each of the TNP peptides was obtained that was highly hapten-specific; however, there were considerable differences in the extent of cross-reactivity with other TNP peptides, with the octamers generating more cross-reactive CTL than the nonamers. MHC restriction analysis suggested that anti-hapten responses were less dependent on MHC recognition than anti-peptide responses. This was evidenced by the relative ease of detecting cross-reactivity to haptenated peptides presented by allo-MHC and by the relative insensitivity of anti-hapten vs anti-peptide CTL to mutations in the Kb molecule at potential TCR interaction sites. One potential explanation for this insensitivity to MHC mutation was the finding that the anti-hapten response appeared to be of higher avidity, since a > 100-fold difference in the amount of Ag required to sensitize target cells was found between these two types of Ags.  (+info)

A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity. (5/1320)

Because substance p (SP) has been reported to be released from cutaneous sensory nerve endings after hapten application, we determined whether SP participates in contact hypersensitivity (CH) induction by using a SP agonist, GR73632 or delta-Aminovaleryl [Pro9, N-Me-Leu10]-substance P(7-11) and a SP antagonist, spantide I. When injected intradermally, SP agonist enhanced CH induced by conventional, but not optimal, sensitizing doses of hapten. By contrast, SP antagonist inhibited the induction of CH by optimal sensitizing doses of hapten. Moreover, SP agonist promoted CH induction and prevented tolerance when hapten was painted on skin exposed to acute, low-dose ultraviolet-B radiation. Intradermally injected SP agonist altered neither the density nor the morphology of epidermal Langerhans cells, implying that SP agonist enhanced the generation of hapten-specific immunogenic signals from the dermis. It is proposed that SP is a natural "adjuvant" that promotes the induction of CH within normal skin. Although exogenous SP agonist can prevent impaired CH and tolerance after ultraviolet-B radiation, the susceptibility of native SP to local neuropeptidases renders the neuropeptide unable to prevent the deleterious effects of ultraviolet-B radiation on cutaneous immunity.  (+info)

Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. (6/1320)

The chronic proliferative dermatitis (cpdm) mutation causes inflammation in multiple organs, most prominently in the skin. Examination of the immune system revealed severe abnormalities in the architecture of lymphoid tissues. Peyer's patches were absent. In contrast, the spleen, lymph nodes, and nasal-associated lymphoid tissues were present. The spleen had normal numbers of T and B cells, but the spleen, lymph nodes, and nasal-associated lymphoid tissues had poorly defined follicles and lacked germinal centers and follicular dendritic cells. The marginal zone in the spleen was absent. The total concentration of serum IgG, IgA, and IgE in cpdm/cpdm mice was significantly decreased, whereas serum IgM was normal. Fecal IgA was low to undetectable in mutant mice, and the concentration of fecal IgM was increased. The titer of DNP-specific Abs following immunization with DNP-keyhole limpet hemocyanin was significantly decreased for all IgG subclasses. In contrast, T cell function appeared normal as assessed by evaluation of the contact hypersensitivity response in cpdm/cpdm mice. The cpdm mutation causes a complex phenotype that is characterized by multiorgan inflammation and the defective development of lymphoid tissues. The cpdm/cpdm mouse may be a useful model to study the factors that control the development of lymphoid tissues, in particular the Peyer's patches, and the mechanisms that control the humoral immune response.  (+info)

Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice. (7/1320)

We previously demonstrated that 2,4,6-trinitrophenol (TNP)-OVA immunization leads to a transmural colitis in the IL-2-/- mouse that is caused by IL-12-driven CD4+ Th1 T cells and resembles human Crohn's disease. The integrin alpha E beta 7 is highly expressed on colonic intraepithelial lymphocytes and has been suggested to function as a homing or retention molecule for intraepithelial lymphocytes. To evaluate the role of alpha E beta 7 in colitis, we administered a mAb against alpha E beta 7 to IL-2-/- mice that were immunized at the same time with TNP-OVA in CFA. To our surprise, this treatment resulted in a significantly reduced colitis severity score, 0-2 vs 3-4, that was associated with a significant reduction in CD4+ lamina propria lymphocyte subpopulation (p < 0.01). In contrast, the total number of splenic CD4+ T cells of treated animals was significantly elevated compared with that of untreated animals (3.2 +/- 0.6 x 107 vs 1.2 +/- 0.2 x 107; p < 0.05). Similarly, functional studies revealed that IFN-gamma production by lamina propria lymphocytes isolated from IL-2-/- TNP-OVA-immunized mice treated with anti-alpha E beta 7 was significantly lower than in untreated IL-2-/- TNP-OVA-immunized mice. In contrast, IFN-gamma production by splenic cells isolated from treated IL-2-/- TNP-OVA-immunized mice was significantly higher than in untreated mice. Finally, TNP-OVA-immunized IL-2-/- mice that were treated after the colitis had been established also showed a significant decrease in mucosal inflammation after alpha E beta 7 mAb administration. Thus, the above findings demonstrate that the onset and maintenance of inflammatory bowel disease depends on the colonic localization of lamina propria CD4+ lymphocytes expressing alpha E beta 7.  (+info)

Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. (8/1320)

To investigate the potential involvement of T helper (Th)2-type responses in murine models of intestinal inflammation, we used trinitrobenzene sulfonic acid (TNBS)-hapten to induce inflammatory bowel disease in situations where Th1-type responses with interferon (IFN)-gamma synthesis are either diminished or do not occur. Intracolonic administration of TNBS to either normal (IFN-gamma+/+) or Th1-deficient IFN-gamma knockout (IFN-gamma-/-) BALB/c mice resulted in significant colitis. In IFN-gamma-/- mice, crypt inflammation was more severe than in IFN-gamma+/+ mice and was accompanied by hypertrophy of colonic patches with a lymphoepithelium containing M cells and distinct B and T cell zones resembling Peyer's patches. Hapten-specific, colonic patch T cells from both mouse groups exhibited a Th2 phenotype with interleukin (IL)-4 and IL-5 production. TNBS colitis in normal mice treated with anti-IL-4 antibodies or in IL-4(-/-) mice was less severe than in either IFN-gamma+/+ or IFN-gamma-/- mice. Our findings now show that the Th2-type responses in TNBS colitis are associated with colonic patch enlargement and inflammation of the mucosal layer and may represent a model for ulcerative colitis.  (+info)

A hapten is a small molecule that can elicit an immune response only when it is attached to a larger carrier protein. On its own, a hapten is too small to be recognized by the immune system as a foreign substance. However, when it binds to a carrier protein, it creates a new antigenic site that can be detected by the immune system. This process is known as haptenization.

Haptens are important in the study of immunology and allergies because they can cause an allergic response when they bind to proteins in the body. For example, certain chemicals found in cosmetics, drugs, or industrial products can act as haptens and trigger an allergic reaction when they come into contact with the skin or mucous membranes. The resulting immune response can cause symptoms such as rash, itching, or inflammation.

Haptens can also be used in the development of vaccines and diagnostic tests, where they are attached to carrier proteins to stimulate an immune response and produce specific antibodies that can be measured or used for therapy.

Dinitrobenzenes are a group of organic compounds that contain two nitro groups (-NO2) attached to a benzene ring. There are three isomers of dinitrobenzenes, depending on the position of the nitro groups on the benzene ring:
1. 1,2-Dinitrobenzene: This isomer has both nitro groups attached to adjacent carbon atoms on the benzene ring. It is a yellow crystalline solid with a melting point of 89-90°C and is soluble in organic solvents such as ethanol, ether, and benzene.
2. 1,3-Dinitrobenzene: This isomer has the nitro groups attached to carbon atoms separated by one carbon atom on the benzene ring. It is a white crystalline solid with a melting point of 90°C and is soluble in organic solvents such as ethanol, ether, and benzene.
3. 1,4-Dinitrobenzene: This isomer has the nitro groups attached to opposite carbon atoms on the benzene ring. It is a white crystalline solid with a melting point of 169°C and is soluble in organic solvents such as ethanol, ether, and benzene.
Dinitrobenzenes are used in chemical synthesis, particularly in the production of dyes, pharmaceuticals, and explosives. However, they are also known to be toxic and can cause skin irritation, respiratory problems, and damage to the liver and kidneys if ingested or inhaled in large quantities. Therefore, handling and use of these compounds should be done with caution and appropriate safety measures.

Contact dermatitis is a type of inflammation of the skin that occurs when it comes into contact with a substance that the individual has developed an allergic reaction to or that causes irritation. It can be divided into two main types: allergic contact dermatitis and irritant contact dermatitis.

Allergic contact dermatitis is caused by an immune system response to a substance, known as an allergen, which the individual has become sensitized to. When the skin comes into contact with this allergen, it triggers an immune reaction that results in inflammation and characteristic symptoms such as redness, swelling, itching, and blistering. Common allergens include metals (such as nickel), rubber, medications, fragrances, and cosmetics.

Irritant contact dermatitis, on the other hand, is caused by direct damage to the skin from a substance that is inherently irritating or corrosive. This can occur after exposure to strong acids, alkalis, solvents, or even prolonged exposure to milder irritants like water or soap. Symptoms of irritant contact dermatitis include redness, pain, burning, and dryness at the site of contact.

The treatment for contact dermatitis typically involves avoiding further exposure to the allergen or irritant, as well as managing symptoms with topical corticosteroids, antihistamines, or other medications as needed. In some cases, patch testing may be performed to identify specific allergens that are causing the reaction.

Catalytic antibodies, also known as abzymes or catalytic immune proteins, are a type of antibody that possesses enzymatic activity. They are capable of accelerating specific chemical reactions in a manner similar to traditional enzymes. This unique property arises from the ability of certain antibodies to bind substrates and promote their conversion into products through a series of chemical transformations.

Catalytic antibodies are generated by immunizing an organism with a transition state analogue, a molecule that mimics the high-energy, transient structure of a substrate during a chemical reaction. The immune system recognizes this analogue as foreign and produces antibodies against it. Some of these antibodies will bind to the transition state analogue in a way that stabilizes its geometry and lowers the energy barrier for the conversion of the substrate into the product. This results in the formation of a catalytic antibody, which can then accelerate this specific chemical reaction when presented with the appropriate substrate.

These specialized antibodies have attracted significant interest in the fields of chemistry, biochemistry, and immunology due to their potential applications in various areas, including drug design, diagnostics, and environmental monitoring. However, it is important to note that catalytic antibodies are still a subject of ongoing research, and their use as practical tools in these applications is not yet widespread.

Dinitrophenols (DNP) are a class of chemical compounds that contain two nitro groups (-NO2) attached to a phenol group. Dinitrophenols have been used in the past as industrial dyes, wood preservatives, and pesticides. However, they have also been misused as weight loss supplements due to their ability to increase metabolic rate and cause weight loss.

The use of DNP for weight loss is dangerous and has been linked to several fatalities. DNP works by disrupting the normal functioning of the mitochondria in cells, which are responsible for producing energy. This disruption causes an increase in metabolic rate, leading to a rapid breakdown of fat and carbohydrates, and ultimately weight loss. However, this increased metabolism can also produce excessive heat, leading to hyperthermia, dehydration, and damage to organs such as the heart, liver, and kidneys.

Due to their potential for serious harm, DNP-containing products are banned in many countries, including the United States. Medical professionals should be aware of the dangers associated with DNP use and advise patients accordingly.

Oxazolone is not a medical condition or diagnosis, but rather a chemical compound. It is commonly used in research and scientific studies as an experimental contact sensitizer to induce allergic contact dermatitis in animal models. Here's the general definition:

Oxazolone (C8H7NO3): An organic compound that belongs to the class of heterocyclic compounds known as oxazoles, which contain a benzene fused to a five-membered ring containing one oxygen atom and one nitrogen atom. It is used in research as an allergen to induce contact hypersensitivity reactions in skin sensitization studies.

Dinitrofluorobenzene (DNFB) is a chemical compound that is often used in laboratory settings for research purposes. It is an aromatic organic compound that contains two nitro groups and a fluorine atom attached to a benzene ring. Dinitrofluorobenzene is primarily known for its ability to act as a hapten, which means it can bind to proteins in the body and stimulate an immune response.

In medical research, DNFB has been used as a contact sensitizer to study the mechanisms of allergic contact dermatitis, a type of skin reaction that occurs when the immune system becomes sensitized to a particular substance and then reacts to it upon subsequent exposure. When applied to the skin, DNFB can cause a red, itchy, and painful rash in individuals who have been previously sensitized to the compound. By studying this reaction, researchers can gain insights into the immune responses that underlie allergic reactions more broadly.

It is important to note that dinitrofluorobenzene is not used as a therapeutic agent in clinical medicine and should only be handled by trained professionals in a controlled laboratory setting due to its potential hazards, including skin and eye irritation, respiratory problems, and potential long-term health effects.

Nitrobenzenes are organic compounds that contain a nitro group (-NO2) attached to a benzene ring. The chemical formula for nitrobenzene is C6H5NO2. It is a pale yellow, oily liquid with a characteristic sweet and unpleasant odor. Nitrobenzene is not produced or used in large quantities in the United States, but it is still used as an intermediate in the production of certain chemicals.

Nitrobenzenes are classified as toxic and harmful if swallowed, inhaled, or if they come into contact with the skin. They can cause irritation to the eyes, skin, and respiratory tract, and prolonged exposure can lead to more serious health effects such as damage to the nervous system and liver. Nitrobenzenes are also considered to be potential carcinogens, meaning that they may increase the risk of cancer with long-term exposure.

In a medical setting, nitrobenzene poisoning is rare but can occur if someone is exposed to large amounts of this chemical. Symptoms of nitrobenzene poisoning may include headache, dizziness, nausea, vomiting, and difficulty breathing. In severe cases, it can cause convulsions, unconsciousness, and even death. If you suspect that you or someone else has been exposed to nitrobenzenes, it is important to seek medical attention immediately.

A binding site on an antibody refers to the specific region on the surface of the antibody molecule that can recognize and bind to a specific antigen. Antibodies are proteins produced by the immune system in response to the presence of foreign substances called antigens. They have two main functions: to neutralize the harmful effects of antigens and to help eliminate them from the body.

The binding site of an antibody is located at the tips of its Y-shaped structure, formed by the variable regions of the heavy and light chains of the antibody molecule. These regions contain unique amino acid sequences that determine the specificity of the antibody for a particular antigen. The binding site can recognize and bind to a specific epitope or region on the antigen, forming an antigen-antibody complex.

The binding between the antibody and antigen is highly specific and depends on non-covalent interactions such as hydrogen bonds, van der Waals forces, and electrostatic attractions. This interaction plays a crucial role in the immune response, as it allows the immune system to recognize and eliminate pathogens and other foreign substances from the body.

Trinitrobenzenes are not typically referred to in the context of medical definitions, as they are chemical compounds that do not have direct relevance to medical fields. However, I can provide you with some general information about trinitrobenzenes.

Trinitrobenzenes are a group of chemical compounds consisting of a benzene ring (a cyclic aromatic hydrocarbon) with three nitro groups (-NO2) attached to it. The most common and well-known compound in this group is 1,3,5-trinitrobenzene (TNB). These compounds are highly explosive and have been used in military and industrial applications for their energetic properties.

In a medical or clinical context, trinitrobenzenes may be encountered only if someone is exposed to these chemicals in an occupational or accidental setting. Exposure can lead to local skin irritation, eye damage, or respiratory issues. Chronic exposure or high-dose acute exposure might cause more severe health problems, including damage to the liver and kidneys. However, trinitrobenzenes are not used as therapeutic agents or diagnostic tools in medicine.

I'm sorry for any confusion, but "Nitrohydroxyiodophenylacetate" doesn't appear to be a recognized or established medical term or substance. It's possible that there might be a mistake in the spelling or terminology.

If you meant "Hypoiodite," that is a medical term, but it refers to a compound that contains iodine in the +1 oxidation state, typically as a solution of iodine in sodium hydroxide (NaOH).

If you could provide more context or clarify the term, I'd be happy to help further!

Gamma-globulins are a type of protein found in the blood serum, specifically a class of immunoglobulins (antibodies) known as IgG. They are the most abundant type of antibody and provide long-term defense against bacterial and viral infections. Gamma-globulins can also be referred to as "gamma globulin" or "gamma immune globulins."

These proteins are produced by B cells, a type of white blood cell, in response to an antigen (a foreign substance that triggers an immune response). IgG gamma-globulins have the ability to cross the placenta and provide passive immunity to the fetus. They can be measured through various medical tests such as serum protein electrophoresis (SPEP) or immunoelectrophoresis, which are used to diagnose and monitor conditions related to immune system disorders, such as multiple myeloma or primary immunodeficiency diseases.

In addition, gamma-globulins can be administered therapeutically in the form of intravenous immunoglobulin (IVIG) to provide passive immunity for patients with immunodeficiencies, autoimmune disorders, or infectious diseases.

An antigen-antibody reaction is a specific immune response that occurs when an antigen (a foreign substance, such as a protein or polysaccharide on the surface of a bacterium or virus) comes into contact with a corresponding antibody (a protective protein produced by the immune system in response to the antigen). The antigen and antibody bind together, forming an antigen-antibody complex. This interaction can neutralize the harmful effects of the antigen, mark it for destruction by other immune cells, or activate complement proteins to help eliminate the antigen from the body. Antigen-antibody reactions are a crucial part of the adaptive immune response and play a key role in the body's defense against infection and disease.

Antibody formation, also known as humoral immune response, is the process by which the immune system produces proteins called antibodies in response to the presence of a foreign substance (antigen) in the body. This process involves several steps:

1. Recognition: The antigen is recognized and bound by a type of white blood cell called a B lymphocyte or B cell, which then becomes activated.
2. Differentiation: The activated B cell undergoes differentiation to become a plasma cell, which is a type of cell that produces and secretes large amounts of antibodies.
3. Antibody production: The plasma cells produce and release antibodies, which are proteins made up of four polypeptide chains (two heavy chains and two light chains) arranged in a Y-shape. Each antibody has two binding sites that can recognize and bind to specific regions on the antigen called epitopes.
4. Neutralization or elimination: The antibodies bind to the antigens, neutralizing them or marking them for destruction by other immune cells. This helps to prevent the spread of infection and protect the body from harmful substances.

Antibody formation is an important part of the adaptive immune response, which allows the body to specifically recognize and respond to a wide variety of pathogens and foreign substances.

I'm sorry for any confusion, but "p-Azobenzenearsonate" doesn't seem to have a specific medical definition. The term "azobenzenearsonate" refers to a type of chemical compound known as an azo dye, which is formed by the reaction between diazonium salts and phenols. These compounds are widely used in the textile industry for dyeing and printing.

However, I did find some research where "p-azobenzenearsonate" was used as a photosensitive molecule to study its effects on cells, but it is not a term commonly used in medical terminology. If you are referring to a specific medical context or application for this compound, could you please provide more details? I'll do my best to give you accurate and helpful information based on the context you provide.

Bispecific antibodies are a type of artificial protein that have been engineered to recognize and bind to two different antigens simultaneously. They are created by combining two separate antibody molecules, each with a unique binding site, into a single entity. This allows the bispecific antibody to link two cells or proteins together, bringing them into close proximity and facilitating various biological processes.

In the context of medicine and immunotherapy, bispecific antibodies are being investigated as a potential treatment for cancer and other diseases. For example, a bispecific antibody can be designed to recognize a specific tumor-associated antigen on the surface of cancer cells, while also binding to a component of the immune system, such as a T cell. This brings the T cell into close contact with the cancer cell, activating the immune system and triggering an immune response against the tumor.

Bispecific antibodies have several potential advantages over traditional monoclonal antibodies, which only recognize a single antigen. By targeting two different epitopes or antigens, bispecific antibodies can increase the specificity and affinity of the interaction, reducing off-target effects and improving therapeutic efficacy. Additionally, bispecific antibodies can bring together multiple components of the immune system, amplifying the immune response and enhancing the destruction of cancer cells.

Overall, bispecific antibodies represent a promising new class of therapeutics that have the potential to revolutionize the treatment of cancer and other diseases. However, further research is needed to fully understand their mechanisms of action and optimize their clinical use.

Antibodies are proteins produced by the immune system in response to the presence of a foreign substance, such as a bacterium or virus. They are capable of identifying and binding to specific antigens (foreign substances) on the surface of these invaders, marking them for destruction by other immune cells. Antibodies are also known as immunoglobulins and come in several different types, including IgA, IgD, IgE, IgG, and IgM, each with a unique function in the immune response. They are composed of four polypeptide chains, two heavy chains and two light chains, that are held together by disulfide bonds. The variable regions of the heavy and light chains form the antigen-binding site, which is specific to a particular antigen.

Myeloma proteins, also known as monoclonal immunoglobulins or M-proteins, are entire or abnormal immunoglobulin (antibody) molecules produced by a single clone of plasma cells, which are malignant in the case of multiple myeloma and some related disorders. These proteins accumulate in the blood and/or urine and can cause damage to various organs and tissues.

In multiple myeloma, the excessive proliferation of these plasma cells leads to the overproduction of a single type of immunoglobulin or its fragments, which can be detected and quantified in serum and/or urine electrophoresis. The most common types of myeloma proteins are IgG and IgA, followed by light chains (Bence Jones proteins) and, less frequently, IgD and IgM.

The presence and levels of myeloma proteins are important diagnostic markers for multiple myeloma and related disorders, such as monoclonal gammopathy of undetermined significance (MGUS) and Waldenström macroglobulinemia. Regular monitoring of these proteins helps assess the disease's activity, response to treatment, and potential complications like kidney dysfunction or amyloidosis.

Nitrophenols are organic compounds that contain a hydroxyl group (-OH) attached to a phenyl ring (aromatic hydrocarbon) and one or more nitro groups (-NO2). They have the general structure R-C6H4-NO2, where R represents the hydroxyl group.

Nitrophenols are known for their distinctive yellow to brown color and can be found in various natural sources such as plants and microorganisms. Some common nitrophenols include:

* p-Nitrophenol (4-nitrophenol)
* o-Nitrophenol (2-nitrophenol)
* m-Nitrophenol (3-nitrophenol)

These compounds are used in various industrial applications, including dyes, pharmaceuticals, and agrochemicals. However, they can also be harmful to human health and the environment, as some nitrophenols have been identified as potential environmental pollutants and may pose risks to human health upon exposure.

Antibody specificity refers to the ability of an antibody to bind to a specific epitope or antigenic determinant on an antigen. Each antibody has a unique structure that allows it to recognize and bind to a specific region of an antigen, typically a small portion of the antigen's surface made up of amino acids or sugar residues. This highly specific binding is mediated by the variable regions of the antibody's heavy and light chains, which form a pocket that recognizes and binds to the epitope.

The specificity of an antibody is determined by its unique complementarity-determining regions (CDRs), which are loops of amino acids located in the variable domains of both the heavy and light chains. The CDRs form a binding site that recognizes and interacts with the epitope on the antigen. The precise fit between the antibody's binding site and the epitope is critical for specificity, as even small changes in the structure of either can prevent binding.

Antibody specificity is important in immune responses because it allows the immune system to distinguish between self and non-self antigens. This helps to prevent autoimmune reactions where the immune system attacks the body's own cells and tissues. Antibody specificity also plays a crucial role in diagnostic tests, such as ELISA assays, where antibodies are used to detect the presence of specific antigens in biological samples.

Hemocyanin is a copper-containing protein found in the blood of some mollusks and arthropods, responsible for oxygen transport. Unlike hemoglobin in vertebrates, which uses iron to bind oxygen, hemocyanins have copper ions that reversibly bind to oxygen, turning the blood blue when oxygenated. When deoxygenated, the color of the blood is pale blue-gray. Hemocyanins are typically found in a multi-subunit form and are released into the hemolymph (the equivalent of blood in vertebrates) upon exposure to air or oxygen. They play a crucial role in supplying oxygen to various tissues and organs within these invertebrate organisms.

Phenylacetates are a group of organic compounds that contain a phenyl group (a benzene ring with a hydroxyl group) and an acetic acid group. In the context of medicine, sodium phenylacetate is used in the treatment of certain metabolic disorders, such as urea cycle disorders, to help remove excess ammonia from the body. It does this by conjugating with glycine to form phenylacetylglutamine, which can then be excreted in the urine.

It is important to note that the use of phenylacetates should be under the supervision of a medical professional, as improper use or dosage can lead to serious side effects.

Antibody-producing cells, also known as plasma cells, are a type of white blood cell that is responsible for producing and secreting antibodies in response to a foreign substance or antigen. These cells are derived from B lymphocytes, which become activated upon encountering an antigen and differentiate into plasma cells.

Once activated, plasma cells can produce large amounts of specific antibodies that bind to the antigen, marking it for destruction by other immune cells. Antibody-producing cells play a crucial role in the body's humoral immune response, which helps protect against infection and disease.

I'm sorry for any confusion, but "Hemolytic Plaque Technique" is not a widely recognized or established medical term. It seems like it might be a combination of two different concepts in medical and scientific research: the Hemolytic Assay and the Plaque Assay technique.

A Hemolytic Assay is a method used to measure the amount of hemolysis, or the rupturing of red blood cells, caused by a substance such as a toxin or an antibody. This assay can help determine the concentration of the hemolysin in a sample.

On the other hand, the Plaque Assay Technique is a method used to measure the number of infectious virus particles in a sample. It involves adding a layer of cells (like bacteria) that the virus can infect and then covering it with a nutrient agar overlay. After a period of incubation, clear areas or "plaques" appear in the agar where the viruses have infected and lysed the cells. By counting these plaques, researchers can estimate the number of infectious virus particles present in the original sample.

Therefore, if you're looking for a definition of a Hemolytic Plaque Technique, it might refer to a research method that combines both concepts, possibly measuring the amount of a substance (like an antibody) that causes hemolysis in red blood cells and correlating it with the number of infectious virus particles present. However, I would recommend consulting the original source or author for clarification on their intended meaning.

Bovine Serum Albumin (BSA) is not a medical term per se, but a biochemical term. It is widely used in medical and biological research. Here's the definition:

Bovine Serum Albumin is a serum albumin protein derived from cows. It is often used as a stabilizer, an emulsifier, or a protein source in various laboratory and industrial applications, including biochemical experiments, cell culture media, and diagnostic kits. BSA has a high solubility in water and can bind to many different types of molecules, making it useful for preventing unwanted interactions between components in a solution. It also has a consistent composition and is relatively inexpensive compared to human serum albumin, which are factors that contribute to its widespread use.

An epitope is a specific region on the surface of an antigen (a molecule that can trigger an immune response) that is recognized by an antibody, B-cell receptor, or T-cell receptor. It is also commonly referred to as an antigenic determinant. Epitopes are typically composed of linear amino acid sequences or conformational structures made up of discontinuous amino acids in the antigen. They play a crucial role in the immune system's ability to differentiate between self and non-self molecules, leading to the targeted destruction of foreign substances like viruses and bacteria. Understanding epitopes is essential for developing vaccines, diagnostic tests, and immunotherapies.

An antigen is a substance (usually a protein) that is recognized as foreign by the immune system and stimulates an immune response, leading to the production of antibodies or activation of T-cells. Antigens can be derived from various sources, including bacteria, viruses, fungi, parasites, and tumor cells. They can also come from non-living substances such as pollen, dust mites, or chemicals.

Antigens contain epitopes, which are specific regions on the antigen molecule that are recognized by the immune system. The immune system's response to an antigen depends on several factors, including the type of antigen, its size, and its location in the body.

In general, antigens can be classified into two main categories:

1. T-dependent antigens: These require the help of T-cells to stimulate an immune response. They are typically larger, more complex molecules that contain multiple epitopes capable of binding to both MHC class II molecules on antigen-presenting cells and T-cell receptors on CD4+ T-cells.
2. T-independent antigens: These do not require the help of T-cells to stimulate an immune response. They are usually smaller, simpler molecules that contain repetitive epitopes capable of cross-linking B-cell receptors and activating them directly.

Understanding antigens and their properties is crucial for developing vaccines, diagnostic tests, and immunotherapies.

Azo compounds are organic compounds characterized by the presence of one or more azo groups (-N=N-) in their molecular structure. The term "azo" is derived from the Greek word "azō," meaning "to boil" or "to sparkle," which refers to the brightly colored nature of many azo compounds.

These compounds are synthesized by the reaction between aromatic amines and nitrous acid or its derivatives, resulting in the formation of diazonium salts, which then react with another aromatic compound containing an active methylene group to form azo compounds.

Azo compounds have diverse applications across various industries, including dyes, pigments, pharmaceuticals, and agrochemicals. They are known for their vibrant colors, making them widely used as colorants in textiles, leather, paper, and food products. In addition, some azo compounds exhibit unique chemical properties, such as solubility, stability, and reactivity, which make them valuable intermediates in the synthesis of various organic compounds.

However, certain azo compounds have been found to pose health risks due to their potential carcinogenicity and mutagenicity. As a result, regulations have been imposed on their use in consumer products, particularly those intended for oral consumption or direct skin contact.

Immunoglobulin (Ig) Fab fragments are the antigen-binding portions of an antibody that result from the digestion of the whole antibody molecule by enzymes such as papain. An antibody, also known as an immunoglobulin, is a Y-shaped protein produced by the immune system to identify and neutralize foreign substances like bacteria, viruses, or toxins. The antibody has two identical antigen-binding sites, located at the tips of the two shorter arms, which can bind specifically to a target antigen.

Fab fragments are formed when an antibody is cleaved by papain, resulting in two Fab fragments and one Fc fragment. Each Fab fragment contains one antigen-binding site, composed of a variable region (Fv) and a constant region (C). The Fv region is responsible for the specificity and affinity of the antigen binding, while the C region contributes to the effector functions of the antibody.

Fab fragments are often used in various medical applications, such as immunodiagnostics and targeted therapies, due to their ability to bind specifically to target antigens without triggering an immune response or other effector functions associated with the Fc region.

Immunization is defined medically as the process where an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. The vaccine stimulates the body's own immune system to recognize and fight off the specific disease-causing organism, thereby preventing or reducing the severity of future infections with that organism.

Immunization can be achieved actively, where the person is given a vaccine to trigger an immune response, or passively, where antibodies are transferred to the person through immunoglobulin therapy. Immunizations are an important part of preventive healthcare and have been successful in controlling and eliminating many infectious diseases worldwide.

Antibody affinity refers to the strength and specificity of the interaction between an antibody and its corresponding antigen at a molecular level. It is a measure of how strongly and selectively an antibody binds to its target antigen. A higher affinity indicates a more stable and specific binding, while a lower affinity suggests weaker and less specific interactions. Affinity is typically measured in terms of the dissociation constant (Kd), which describes the concentration of antigen needed to achieve half-maximal binding to an antibody. Generally, a smaller Kd value corresponds to a higher affinity, indicating a tighter and more selective bond. This parameter is crucial in the development of diagnostic and therapeutic applications, such as immunoassays and targeted therapies, where high-affinity antibodies are preferred for improved sensitivity and specificity.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Cross reactions, in the context of medical diagnostics and immunology, refer to a situation where an antibody or a immune response directed against one antigen also reacts with a different antigen due to similarities in their molecular structure. This can occur in allergy testing, where a person who is allergic to a particular substance may have a positive test result for a different but related substance because of cross-reactivity between them. For example, some individuals who are allergic to birch pollen may also have symptoms when eating certain fruits, such as apples, due to cross-reactive proteins present in both.

Dinitrochlorobenzene (DNCB) is a chemical compound that is classified as an aromatic organic compound. Its medical definition relates to its use as a topical immunotherapy for the treatment of certain skin conditions. DNCB is a potent sensitizer and hapten, which means that it can cause an immune response when it comes into contact with the skin.

When applied to the skin, DNCB can stimulate the production of antibodies and activate immune cells, leading to an inflammatory reaction. This property has been exploited in the treatment of conditions such as alopecia areata, a type of hair loss that is thought to be caused by an autoimmune response. By sensitizing the patient's immune system to DNCB, it may be possible to modulate the immune response and promote hair growth.

However, the use of DNCB as a therapeutic agent is not without risks. It can cause significant local reactions, including redness, swelling, and blistering, and there is a risk of systemic toxicity if it is absorbed into the bloodstream. As such, its use is generally restricted to specialized medical settings where it can be administered under close supervision.

Langerhans cells are specialized dendritic cells that are found in the epithelium, including the skin (where they are named after Paul Langerhans who first described them in 1868) and mucous membranes. They play a crucial role in the immune system as antigen-presenting cells, contributing to the initiation of immune responses.

These cells contain Birbeck granules, unique organelles that are involved in the transportation of antigens from the cell surface to the lysosomes for processing and presentation to T-cells. Langerhans cells also produce cytokines, which help regulate immune responses and attract other immune cells to the site of infection or injury.

It is important to note that although Langerhans cells are a part of the immune system, they can sometimes contribute to the development of certain skin disorders, such as allergic contact dermatitis and some forms of cancer, like Langerhans cell histiocytosis.

Irritants, in a medical context, refer to substances or factors that cause irritation or inflammation when they come into contact with bodily tissues. These substances can cause a range of reactions depending on the type and duration of exposure, as well as individual sensitivity. Common examples include chemicals found in household products, pollutants, allergens, and environmental factors like extreme temperatures or friction.

When irritants come into contact with the skin, eyes, respiratory system, or mucous membranes, they can cause symptoms such as redness, swelling, itching, pain, coughing, sneezing, or difficulty breathing. In some cases, prolonged exposure to irritants can lead to more serious health problems, including chronic inflammation, tissue damage, and disease.

It's important to note that irritants are different from allergens, which trigger an immune response in sensitive individuals. While both can cause similar symptoms, the underlying mechanisms are different: allergens cause a specific immune reaction, while irritants directly affect the affected tissues without involving the immune system.

Once the body has generated antibodies to a hapten-carrier adduct, the small-molecule hapten may also be able to bind to the ... Sometimes the small-molecule hapten can even block immune response to the hapten-carrier adduct by preventing the adduct from ... who also pioneered the use of synthetic haptens to study immunochemical phenomena. Haptens applied on skin, when conjugate with ... A lot of haptens are comprised in different kinds of drugs, pesticides, hormones, food toxins etc. Most important factor is the ...
Metal allergies are type IV allergies; the metals are haptens. The toxicity of some allergenic metals may contribute to the ...
Also connecting two haptens via a two amino acid linker resulted in an enhancement effect of the affinity, which improved the ... Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery ... enhanced divalent hapten affinity for cell-bound antibody conjugate". Journal of Nuclear Medicine. 30 (8): 1358-1366. ISSN 0161 ... "In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody ...
... is a hapten inhibitor that greatly reduces the risk for anaphylactic reactions when administering dextran. Dextran 1 ... Ljungstrom, K.; Willman, B.; Hedin, H. (1993). "Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing ...
Holzer, A. M.; Kaplan, L. L.; Levis, W. R. (2006). "Haptens as drugs: contact allergens are powerful topical immunomodulators ...
1985-01-01). "Chapter 4 The nature of immunogens, antigens, and haptens". Laboratory Techniques in Biochemistry and Molecular ...
... and abundance of lysine residues for coupling haptens allows a high hapten:carrier protein ratio, increasing the likelihood of ... Haptens are substances with a low molecular weight such as peptides, small proteins and drug molecules that are generally not ... Haptens can be coupled to KLH using several methods. A simple one-step coupling can be performed using the carbodiimide ... A sulfhydryl-containing hapten can then be reacted with the KLH to complete the immunogen without causing polymerization. The ...
The hapten-carrier complex, unlike free hapten, can act as an immunogen and can induce an immune response. Until 1959, the ... An explicit example is a hapten. Haptens are low-molecular-weight compounds that may be bound by antibodies, but cannot elicit ... Consequently, the haptens themselves are nonimmunogenic and they cannot evoke an immune response until they bind with a larger ... All immunogens are antigens, but some antigen are not immunogens (e.g. haptens) Abbas A.K.; Lichtman A.H.; Pillai S. (2012). ...
"Syndecan-1 regulates dendritic cell migration in cutaneous hypersensitivity to haptens". Experimental Dermatology. 26 (11): ...
Karl Landsteiner pioneered the use of haptens for research in immunochemistry. Landsteiner's techniques were developed by ...
It is a hapten used in vaccine preparation. Dinitrophenyl does not elicit any immune response on its own and it does not bind ...
Singh MK, Srivastava S, Raghava GP, Varshney GC (January 2006). "HaptenDB: a comprehensive database of haptens, carrier ... proteins and anti-hapten antibodies". Bioinformatics. 22 (2): 253-5. doi:10.1093/bioinformatics/bti692. PMID 16443637. Wang X, ...
Most drugs do not cause reactions in themselves, but by the formation of haptens. Drug allergies or hypersensitivities can be ...
The assay uses hapten-labelled nucleotides in a primer extension reaction. The hapten label is recognized by anti-bodies, which ...
Hybridization is followed by single-base extension with hapten-labeled dideoxynucleotides. The ddCTP and ddGTP are labeled with ... Fluorescence staining and scanning of chip After incorporation of these hapten-labeled ddNTPs, multi-layered ...
... it was linked to their hapten feature or, if the parent compound lacked hapten characteristics, a hapten feature of a drug ... Thus, the list of drugs acting via p-i and causing DHR is now longer than the list of hapten-like drugs (table). First hapten, ... Extensive in vitro and in vivo data support the hapten concept in contact dermatitis. It was tempting to use the hapten model ... This is best achieved using hapten (and thus antigenic) features of a drug. Indeed, the classical hapten-drugs beta-lactam ...
Yu, Baofa; Lu, Yuanfei (2014). "Hapten-enhanced personalized chemoimmunotherapy by intratumoral drug delivery in advanced ... "Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral ... "Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral ... "Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral ...
Hapten, small molecules that can elicit an immune response under certain conditions. Mango trees, which may cause cross- ... Instead, it attaches to certain proteins of the skin, where it acts as a hapten, leading to a type IV hypersensitivity reaction ...
Yi YS, Ayala-López W, Kularatne SA, Low PS (July 2009). "Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: ... comparison of hapten potencies". Mol. Pharm. 6 (4): 1228-36. doi:10.1021/mp900070b. PMID 19374407. Amato, R.J., Fagbeyiro, B., ...
DNA regions of interest are observed by hybridising them with probes labelled by haptens like biotin; this can then be bound by ...
Work on the compound is ongoing under Hapten Sciences, who licensed the university's research in 2010. The compound has been ... Jefferson R (22 September 2021). "University of Mississippi and Hapten's Poison Ivy Vaccine Development Now in Clinical Trials ...
These molecules that are so small, they act as haptens and bind to larger molecules to induce an immune response. An allergic ... response is induced when T lymphocytes recognize these haptens and recruit professional antigen-presenting cells. IgE ...
PFP esters are useful for attaching fluorophores such as fluorescein or haptens to primary amines in biomolecules. They also ...
The linker is vital for linking the hapten to the carrier protein, providing the appropriate geometry for the binding of hapten ... Linkers also ensure that the number of nicotine haptens available for binding to B cells is optimal. The carrier proteins used ... A drug molecule with its structural composition altered and a chemical linker connected is referred to as a hapten. The ... Nicotine vaccines are immunogens made up of synthetic drug haptens connected to immunogenic carriers, which are then packaged ...
"Biosynthesis of Forssman hapten from globoside by alpha-N-acetylgalactosaminyltransferase of guinea pig tissues". Biochem. ...
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases. Int J ...
Tetrafluorophenyl (TFP) ester chemistry is typically used to attach fluorophores or haptens to the primary amines of ...
https://doi.org/10.1128/mBio.01914-20 Kunin, C. M.; Beard, M. V.; Halmagyi, N. E. (962). "Evidence for a Common Hapten ...
... the hapten model and the autoantibody model. The hapten model proposes that certain drugs, especially penicillin and ... cephalosporins, will bind to certain proteins on the red cell membrane and act as haptens (small molecules that can elicit an ...
Repeated administration of antibiotics, which can form haptens to cause allergic reactions, can also reduce antibiotic ...
Once the body has generated antibodies to a hapten-carrier adduct, the small-molecule hapten may also be able to bind to the ... Sometimes the small-molecule hapten can even block immune response to the hapten-carrier adduct by preventing the adduct from ... who also pioneered the use of synthetic haptens to study immunochemical phenomena. Haptens applied on skin, when conjugate with ... A lot of haptens are comprised in different kinds of drugs, pesticides, hormones, food toxins etc. Most important factor is the ...
The Scientists articles tagged with: hapten
BROWSE BY CATEGORY > Cell Biology > Reactive Haptens. ©1998 - 2023 BiosciRegister TERMS OF USE , PRIVACY , EDIT LISTING , ...
Haptens core asset is intellectual property licensed from the University of Mississippi, said Stevenson. Hapten was founded by ... Tags: , Brian Evans, Cagenix, Claritas Capital, Consensus Point, FanLab, Farsheed Ferdowsi, FDA, Gary Prosterman, Hapten ... The Hapten concept faces development, animal and human trials and the required review by the Food and Drug Administration. ... In addition, Memphis Biomed Ventures Tennessee (MBVT) announced it has invested $800,000 in Hapten Sciences, in Memphis. Just a ...
CBA × C57B1)F1 mice were primed to the hapten NNP on either of the non-cross-reacting carriers fowl γ-globulin (Fγ G) or ... Hapten-Specific Blockade of CBA/N × C3H/HeN F 1 B Cell Responses in a Cell Transfer System International Archives of Allergy ... Allogeneic Stimulation of Anti-Hapten Response in Mice Subject Area: Immunology and Allergy ... A Simple Hemolytic Plaque Technique for the Enumeration of Anti-Hapten Antibody Forming Cells International Archives of Allergy ...
Contact allergy to haptens in the Swedish baseline series : Results from the Swedish Patch Test Register (2010 to 2017). *Mark ... Background: Allergic contact dermatitis has considerable public health impact and causative haptens vary over time. Objectives ... Background: Allergic contact dermatitis has considerable public health impact and causative haptens vary over time. Objectives ... Contact allergy to haptens in the Swedish baseline series : Results from the Swedish Patch Test Register (2010 to 2017)}}, url ...
Diphenylcyclopropenone (DPC) is an organic chemical hapten which induces allergic contact dermatitis, and is used in treatment ... The clonal structure and dynamics of the human T cell response to an organic chemical hapten. ... The clonal structure and dynamics of the human T cell response to an organic chemical hapten ... The clonal structure and dynamics of the human T cell response to an organic chemical hapten ...
A hapten is a molecule which cannot trigger antibody production on its own. ... A hapten is a molecule which cannot trigger antibody production on its own. ...
Antibodies Against Small Molecule Haptens. Antibodies against small molecule haptens enable robust and rapid detection, ... We recommend analyzing the immunogenic variables of the small molecule hapten and application of interest since each ... the orientation of the hapten on the carrier protein, and linkers used. In addition, the antigen presentation should mimic the ...
Custom Services for Anti-hapten Antibody * Small-molecule Hapten Design and Synthesis * Heavy Metals * Heavy Metals Hapten ... Custom Services for Anti-hapten Antibody * Small-molecule Hapten Design and Synthesis * Heavy Metals * Heavy Metals Hapten ... Fumonisins Hapten Design and Synthesis * Design and Synthesis of Class-specific Haptens for Fumonisin B1 (FB1) ... Steroid Hormones Hapten Design and Synthesis * Design and Synthesis of Class-specific Haptens (D ring) for Steroid Hormones ...
Discover uniqueness of SynAbs monoclonal antibodies technologies!
Thus, this paper addresses the biological plausibility of plantphenolics as pathogen-carrier immunogenicity modulator haptens. ...
SYnAbs singular approach to generate therapeutic antagonist and agonist monoclonal antibodies to ion channels to efficiently treat channelopathies
Ag:IgG IC or Ag plus Hapten?. Haptens are small molecules engineered in such a way that, in combination with a larger carrier ... Some studies suggest that DC-targeted vaccination strategies employing hapten:tumor Ags, or hapten:whole-tumor cell ... hapten challenge followed by the transplantation of hapten-coated tumor cells). Through their ability to target Ags to APCs ... Without additional hapten administration, IgG ICs entailed the bona fide licensing of DCs to induce strong tumoricidal CD8+ CTL ...
One example of this hapten based vaccine is developing a method for conjugation of a morphine-like hapten (MorHap) to tetanus ... Torres OB, Alving CR, Matyas (2016) Synthesis of hapten-protein conjugate vaccines with reproducible hapten densities. In ... Srivastava S, Singh MK, Raghava (2007) Searching Haptens, Carrier Proteins, and Anti-Hapten Antibodies. In Immunoinformatics ... Hapten-Based Vaccination as an Innovative Therapeutic Approach for Drug Addiction Volume 52- Issue 1 ...
... the production of specific IgE antibody to this hapten protein conjugate. ... Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. ... Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. ... Adult, Antibodies, Electronics, Female, Haptens, Humans, Hypersensitivity, Immediate, Immunoglobulin E, Male, Occupational ...
Is Clenbuterol Hapten Succinic Semialdehyde safe?. Yes, Clenbuterol Hapten Succinic Semialdehyde is a safe and non-toxic ... Clenbuterol hapten succinic semialdehyde. Clenbuterol Hapten Succinic Semialdehyde: Effects, Dosage, and Risks ... The Health Advantages of Clenbuterol Hapten Succinic Semialdehyde. Astralean clenbuterol uk. Clenbuterol hapten succinic ... Here are some of the benefits of using clenbuterol hapten succinic semialdehyde:. Increases Muscle Mass: Clenbuterol hapten ...
Thermodynamics of hapten binding to MOPC 315 and MOPC 460 mouse myeloma proteins.. scientific article published in January 1974 ... Thermodynamics of hapten binding to MOPC 315 and MOPC 460 mouse myeloma proteins. (English) ...
Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: Comparison of hapten potencies. Molecular pharmaceutics. ... Folate-targeted hapten immunotherapy of adjuvant-induced arthritis : Comparison of hapten potencies. / Yi, Young Su; Ayala- ... Folate-targeted hapten immunotherapy of adjuvant-induced arthritis : Comparison of hapten potencies. In: Molecular ... title = "Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: Comparison of hapten potencies", ...
Haptens * Hemocyanins / immunology * Immunoconjugates* * Immunoglobulin Class Switching / drug effects * Immunoglobulin Class ...
Dive into the research topics of Induction of the c-myc protooncogene after antigen binding to hapten-specific B cells. ... Induction of the c-myc protooncogene after antigen binding to hapten-specific B cells. ...
The anti-Hapten antibody against hapten [Carprofen] had been validated with our hapten-carrier conjugates [BSA-Carprofen]via ... and hapten-carrier conjugates [BSA-Carprofen] competitive antigens(Carrier-coupled antigen, immunogen, hapten-carrier ... All our anti-chemicals antibodies and small molecules hapten-carrier conjugates antigens (BSA-conjugated , OVA-conjugated)are ... hapten-carrier conjugates, BSA-conjugated , OVA-conjugated) for the rapid test and diagnostics kit of Growth Promoters, Toxic ...
Reactive Haptens. NHS Esters of Biotin. NHS Ester of Biotin enable Biotin labeling of proteins (e.g. antibodies) and any other ... Reactive Fluorescent, Hapten-modified and bifunctional reagents for labeling and crosslinking of biomolecules such as DNA, RNA ...
... or low-avidity hapten-specific B-cell precursors will proliferate in response to challenge with a hapten-carrier conjugate. ... or low-avidity hapten-specific B-cell precursors will proliferate in response to challenge with a hapten-carrier conjugate.", ... or low-avidity hapten-specific B-cell precursors will proliferate in response to challenge with a hapten-carrier conjugate. ... or low-avidity hapten-specific B-cell precursors will proliferate in response to challenge with a hapten-carrier conjugate. ...
Hapten-specific cells grew in soft agar to form discrete colonies. Colony growth is dependent on mitogens present in agar, ... Hapten-specific cells grew in soft agar to form discrete colonies. Colony growth is dependent on mitogens present in agar, ... Hapten-specific cells grew in soft agar to form discrete colonies. Colony growth is dependent on mitogens present in agar, ... Hapten-specific cells grew in soft agar to form discrete colonies. Colony growth is dependent on mitogens present in agar, ...
Haptens activate Toll-like receptors (TLRs) and activate innate immunity. The importance of hapten-mediated activation of ... Haptens or haptenated self-proteins are recognized by innate immune mechanisms in the skin, and this leads to the elaboration ... Although haptens can penetrate through intact skin, patients with certain disease states that impair barrier function (eg, leg ... In the final step, hapten-induced inflammation recruits activated effector T cells back to the initial site of antigen ...
NK cells can exert immunological memory after encounters with stimuli such as haptens or viruses, resulting in the generation ... Immunol. 7, 507-516 (2006). This seminal paper reports the first observation of NK cell memory responses against haptens. ... Immunol. 11, 1127-1135 (2010). This important paper reveals that NK cell memory develops against haptens, influenza virus and ... For example, hapten-specific memory NK cells reside in the liver, influenza virus-specific memory NK cells reside in the liver ...
... the T-cell repertoire results from particular properties of certain TCR to recognize hapten-modified peptides without need for ... the T-cell repertoire results from particular properties of certain TCR to recognize hapten-modified peptides without need for ... Work conducted with synthetic hapten-peptide conjugates showed two major types of hapten-specific TCRs: one reacting to hapten ... In the hapten model, drugs/chemicals or haptens bind to self-proteins to form a complex of a sufficient size to trigger an ...
  • Antibodies against small molecule haptens enable robust and rapid detection, monitoring and quantification using assays such as ELISA or IHC/IF. (prosci-services.com)
  • However, due to the lack of an epitope that can be recognized by T cells to trigger an immune response, tilmicosin is difficult to produce corresponding specific antibodies, so it is called hapten. (creative-biolabs.com)
  • The key is to obtain high-quality antibodies, which depends on rational hapten design. (creative-biolabs.com)
  • The more similar a hapten derivative is to a target, the more likely it is to produce specific antibodies. (creative-biolabs.com)
  • We characterize trends in Tilmicosin antibody production based on sensitivity and specificity, so we tried to immunize BALB/c mice using different hapten strategies for the preparation and screening of high-quality monoclonal antibodies. (creative-biolabs.com)
  • Landsteiner first coined the term "haptenic immune response" to assist generate the idea of detecting anti-hapten antibodies in immunodiagnostics and therapies [11]. (biomedres.us)
  • In this targeted hapten therapy, folate-fluorescein was shown to decorate folate receptor (FR)-expressing activated macrophages with fluorescein (an immunogenic hapten), leading to binding of antifluorescein antibodies and the consequent elimination of the activated macrophages by Fc receptor-expressing immune cells. (houstonmethodist.org)
  • Immunoassays for haptens depend on competitive hapten-anti-hapten reactions, and consequently their sensitivities are significantly influenced by the affinities of anti-hapten antibodies. (lu.se)
  • Haptens applied on skin, when conjugate with a carrier, could induce contact hypersensitivity, which is a type IV delayed hypersensitivity reaction mediated by T cells and dendritic cells. (wikipedia.org)
  • Hapten-heterologous carrier conjugates elicited antihapten titers similar in magnitude to those elicited by the homologous carrier conjugate. (caltech.edu)
  • Creative Biolabs can chemically modify the hapten at the appropriate position to introduce a spacer with an active group at the end, and then couple the modified hapten with a macromolecular carrier to form a hapten-carrier conjugate (eg Artificial antigen). (creative-biolabs.com)
  • The purpose of this article is to share information with researchers and clinicians about creating a vaccine by incorporating a specific substance of abuse in a hapten conjugate that triggers an immune response against the effect of the drug. (biomedres.us)
  • From the chemical standpoint, the hapten is a low molecular weight chemical agent, that must bind to a large carrier protein to create a conjugate (Figure 1), before being detected by the immune system and eliciting an immunological response. (biomedres.us)
  • Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. (ox.ac.uk)
  • Smoking may predispose to, and interact with atopy in, the production of specific IgE antibody to this hapten protein conjugate. (ox.ac.uk)
  • These findings imply that carrier-specific helper T cells do not play a controlling role in determining whether high- or low-avidity hapten-specific B-cell precursors will proliferate in response to challenge with a hapten-carrier conjugate. (johnshopkins.edu)
  • We recommend analyzing the immunogenic variables of the small molecule hapten and application of interest since each application presents antigens in a distinct way. (prosci-services.com)
  • These immunogenic variables include the chemical structure, conjugation method, cross-linking between the small molecule and protein carrier, the orientation of the hapten on the carrier protein, and linkers used. (prosci-services.com)
  • This phenomenon is clinically well known as anergy to tuberculin or other immunogenic haptens after subcutaneous injections. (cdc.gov)
  • Following development of arthritis, rats were treated with one of five folate-hapten conjugates (folate-DNP1, folate-DNP2, folate-DNP3, folate-FITC, or folate-TNP) at two different doses (30 nmol/kg or 200 nmol/kg) 5x/week for 25 days. (houstonmethodist.org)
  • Although all folate-hapten conjugates promoted a reduction in disease symptoms, folate-TNP and folate-FITC proved to be more potent than any of the 3 folate-DNP conjugates. (houstonmethodist.org)
  • Competitive immunoassay-validated hapten-carrier conjugates BSA-Carprofen with anti-Hapten antibody. (genemedi.net)
  • The hapten hapten-carrier conjugates BSA-Carprofen had been validated with our anti-Hapten antibody Anti-Carprofen mouse monoclonal antibody via competitive ELISA test. (genemedi.net)
  • These encompass various forms, such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated variants, designed to cater to diverse scientific needs. (genemedi.net)
  • However, from the cellular perspective, after binding of hapten to a carrier protein and formation of the complexes that are processed inside Antigen Presenting Cells (APCs) and presented as a stable hapten-peptide complex to the major histocompatibility complex class II (MHC II) settled in the tissues, an immune response will begin [13]. (biomedres.us)
  • Sometimes the small-molecule hapten can even block immune response to the hapten-carrier adduct by preventing the adduct from binding to the antibody, a process called hapten inhibition. (wikipedia.org)
  • The sensitization phase where the hapten is applied to the skin for the first time is characterized by the activation of innate immune responses, including migration of dendritic cells to the lymph nodes, priming antigen-specific naive T cells, and the generation of antigen-specific effector or memory T cells and B cells and antibody-secreting plasma cells. (wikipedia.org)
  • The second elicitation phase where the hapten is applied to a different skin area starts with activation of effector T cells followed by T cell-mediated tissue damage and antibody-mediated immune responses. (wikipedia.org)
  • Haptens initially activate innate immune responses by complex mechanisms involving inflammatory cytokines, damage-associated molecular patterns (DAMP), or the inflammasome. (wikipedia.org)
  • In general, a properly designed hapten should highly overlap with the target molecule in a three-dimensional structure and bring stable immunogenicity to induce an immune response. (creative-biolabs.com)
  • Our services include modification of hapten sites, selection of vectors, coupling of hapten derivatives to vectors, and purification and identification of artificial antigens. (creative-biolabs.com)
  • The concept is also used for chemicals as antigens or haptens. (bvsalud.org)
  • The basis of hapten- molecular mechanisms of the sensitization pro- protein binding work is the hypothesis that upon cess will result in novel opportunities for the skin absorption, only protein-reactive chemicals development of alternative methods for assessing (or those that can be metabolically or chemically skin sensitization hazard and relative potency of converted to protein-reactive species) are able to chemicals. (cdc.gov)
  • It has been hypothesised that low molecular weight chemicals could act as haptens and combine with a body protein to form a complete antigen. (bmj.com)
  • This mouse IgG2b, κ isotype control is a monoclonal antibody, clone 27-35, that is specific for the dansyl (5-[dimethylamino] naphthalene-1-sulfonyl) hapten. (bdbiosciences.com)
  • Immunogen and coating antigen were prepared by conjugating hapten, 4-(3-oxo-3-(2,6-dihydroxy-4-glucoside phenyl)propyl) benzoic acid, to thyroglobulin and bovine serum albumin, respectively. (cdc.gov)
  • Haptens have been used to study allergic contact dermatitis (ACD) and the mechanisms of inflammatory bowel disease (IBD) to induce autoimmune-like responses. (wikipedia.org)
  • MB Ventures' Gary Stevenson told VNC that Hapten is developing an injectable pharmaceutical preventative that would, as currently planned, be injected perhaps yearly to ward-off allergic responses to poison ivy, sumac or oak. (venturenashville.com)
  • Background: Allergic contact dermatitis has considerable public health impact and causative haptens vary over time. (lu.se)
  • Diphenylcyclopropenone (DPC) is an organic chemical hapten which induces allergic contact dermatitis, and is used in treatment of warts, melanoma and alopecia areata. (elifesciences.org)
  • The other is called a photoallergy , where exposure to sun radiation converts some drugs into an allergen called a hapten , which produces an allergic response in the skin, likely as a rash or hives. (howstuffworks.com)
  • We also made some experiments on the inhibition of precipitation by added haptens, in order to see how great would be the effects of monohaptenic impurities possibly present in the substances studied. (caltech.edu)
  • This therapeutic setting therefore provided an opportunity to study T cell receptor (TCR) repertoire changes in response to hapten sensitization in humans. (elifesciences.org)
  • Hapten-heterologous carrier recall of antihapten was successful as early as 37 days and as late as 11 months after sensitization. (caltech.edu)
  • There was no correlation between anti-TNP-precipitating antibody titer after sensitization and the ability to respond to challenge by hapten-heterologous carrier. (caltech.edu)
  • Other example of a hapten-mediated contact dermatitis is nickel allergy, which is caused by nickel metal ions penetrating the skin and binding to skin proteins. (wikipedia.org)
  • When absorbed through the skin from a poison ivy plant, urushiol undergoes oxidation in the skin cells to generate the actual hapten, a reactive quinone-type molecule, which then reacts with skin proteins to form hapten adducts. (wikipedia.org)
  • CBA × C57B1)F 1 mice were primed to the hapten NNP on either of the non-cross-reacting carriers fowl γ -globulin (F γ G) or ovalbumin (OV) and 4 weeks later were given 50 × 10 6 CBA or (CBA × C57B1)F 1 spleen cells. (karger.com)
  • The antibody-forming cells were of host origin, and the effect could be induced by T lymphocytes, not by B. When mice were challenged with NNP.F γ G at various intervals after the induction of GVHR, it was found that by 8 days the increased response was seen only in mice primed to hapten on the heterologous carrier (NNP.OV). (karger.com)
  • Hapten-specific murine colony-forming B cells. (usuhs.edu)
  • Hapten-specific cells grew in soft agar to form discrete colonies. (usuhs.edu)
  • Dive into the research topics of 'Hapten-specific murine colony-forming B cells. (usuhs.edu)
  • For example, hapten-specific memory NK cells reside in the liver, influenza virus-specific memory NK cells reside in the liver and lung, and mouse cytomegalovirus (MCMV)-specific NK cells and cytokine-induced memory NK cells are systemically distributed. (nature.com)
  • First, similarly to T cells and B cells, NK cells can exert immunological memory after encounters with stimuli such as haptens or viruses, resulting in the generation of antigen-specific memory NK cells. (nature.com)
  • Haptens may also bind directly to class II MHC molecules, directly activating T cells. (merckmanuals.com)
  • The process is achieved in collaboration between hapten-specific B cells and carrier-specific T cells. (quizlet.com)
  • The dansyl (DNS) hapten is not expressed on human cells or human cell lines. (bdbiosciences.com)
  • This hapten is not expressed on non-human primate cells. (bdbiosciences.com)
  • These observations may also suggest that in the case of drug/chemical allergy, the T-cell repertoire results from particular properties of certain TCR to recognize hapten-modified peptides without need for previous thymic selection. (frontiersin.org)
  • However, most drugs act as haptens, binding covalently to serum or cell-bound proteins, including peptides embedded in major histocompatibility complex (MHC) molecules. (merckmanuals.com)
  • Based on these theories, we designed haptens with short spacer arms or unsaturated double bond arms, and analyzed the similarities between drugs and haptens by molecular simulation. (creative-biolabs.com)
  • Then, two haptens were designed by introducing spacer arms at the C4â ³-OH and C5-OH of ABM, respectively, aiming to provide the longest epitope distances. (bvsalud.org)
  • Hapten Succinic Semialdehyde (HSS) is a derivative of Clenbuterol that has been gaining popularity in the fitness industry due to its unique properties. (alcafricanos.com)
  • In the current study, we compare the therapeutic potencies of a variety of FR-targeted haptens in treating the symptoms of AIA in rats. (houstonmethodist.org)
  • Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. (webmd.com)
  • Thermodynamics of hapten binding to MOPC 315 and MOPC 460 mouse myeloma proteins. (wikidata.org)
  • A well-known example of a hapten is urushiol, which is the toxin found in poison ivy. (wikipedia.org)
  • The presence of dinitrophenyl groups on the immunizing antigen could suppress, partially or completely, the antibody response to p-azophenyl arsonate when this hapten was located on the same molecule. (caltech.edu)
  • Sanfilippo, F & Scott, DW 1976, ' The Effects of carrier-specific helper T-cell tolerance on antibody avidity in the anti-hapten response ', Cellular Immunology , vol. 21, no. 1, pp. 112-120. (johnshopkins.edu)
  • A lot of haptens are comprised in different kinds of drugs, pesticides, hormones, food toxins etc. (wikipedia.org)
  • Drugs of abuse can be considered as haptens. (biomedres.us)
  • The concept of haptens emerged from the work of Austrian immunologist Karl Landsteiner, who also pioneered the use of synthetic haptens to study immunochemical phenomena. (wikipedia.org)
  • The Hapten concept faces development, animal and human trials and the required review by the Food and Drug Administration. (venturenashville.com)
  • What is the hapten-carrier effect? (quizlet.com)
  • In the present study, abamectin (ABM) was selected to prove the effect of hapten design and antibody recognition properties on the development of a sandwich immunoassay for small molecules. (bvsalud.org)
  • After the addition of biotinylated T3 and streptavidin-coated microparticles, the still-free binding sites of the labeled antibody become occupied, with formation of an antibody-hapten complex. (cdc.gov)
  • Three main types of NK cell memory exist, namely hapten-specific NK cell memory, virus-specific NK cell memory and cytokine-induced NK cell memory. (nature.com)
  • Creative Biolabs provides customers with the design and synthesis services of tilmicosin haptens. (creative-biolabs.com)
  • If you want to inquire more about our Tilmicosin hapten design and synthesis services, please contact us . (creative-biolabs.com)
  • Altogether, the study provided a theoretical foundation as well as practical experience and demonstrated the importance of careful hapten design and extensive antibody screening to successfully establish the sandwich immunoassay for small molecules. (bvsalud.org)
  • In the second phase a radiolabeled hapten is administered, which is trapped in the tumor by the bs-mAb. (snmjournals.org)
  • The overlapping side chain structure is far from the derivatizing group of the hapten, so the side chain structure is one of the key binding sites of the antibody and causes high cross-reactivity between Tylosin and Tilmicosin. (creative-biolabs.com)

No images available that match "haptens"